15th INTERNATIONAL CONGRESS OF PARKINSON'S

Abstracts by Topic
938 An a-synuclein 3’-flanking region SNP interacts with Parkinson’s
disease susceptibility via allele-specific binding of a transcription
factor
I. Mizuta, W. Satake, K. Takafuji, M. Kanagawa, K. Kobayashi,
S. Nagamori, Y. Kanai, M. Yamamoto, N. Hattori, M. Murata, T. Toda
(Kyoto, Japan)
939 Transcriptional activation of LINE1 elements in response to age and
heavy metal induced stress in male wistar rats
S. Mukherjee, D. Sharma, K.C. Upadhyaya (New Delhi, Delhi, India)
940 Expression of alpha-synuclein isoforms in familial and sporadic
Parkinson’s disease
E. Mutez, L. Larvor, A. Duflot, C. Vanbesien, V. Mouroux, A. Destée,
M.-C. Chartier-Harlin (Lille, France)
941 Molecular genetic analysis of DYT6/THAP1 gene in Serbian
dystonia patients
I. Novakovic, V. Dobricic, N. Kresojevic, M. Jankovic, I. Petrovic,
M. Svetel, C. Klein, V.S. Kostic (Belgrade, Serbia)
942 Detection of copy number variations for two dosage sensitive genes
(PARK2 and SNCA) in Parkinson’s disease (PD) patients using new
NanoString® technology
K. Nuytemans, G. Bademci, L. Wang, S. Zuchner, F. Nahab, C. Singer,
W. Scott, T. Guettouche, J.M. Vance (Miami, Florida, USA)
943 Whole-exome sequencing and follow-up in an extended Amish
family with Parkinson’s disease (PD)
K. Nuytemans, G. Bademci, Y. Edwards, G. Beecham, M. Davis,
A. Cummings, S. Lee, W. Scott, J. Haines, J.M. Vance (Miami, Florida,
USA)
944 HSP-SPG3A: Unusual clinical characteristics in a black South-
African family
A. Orlacchio, P. Montieri, C. Babalini, G. Bernardi, T. Kawarai (Rome,
Italy)
945 Clinical and genetic spectrum of myoclonus dystonia syndrome
K.J. Peall, A.J. Waite, M.A. Kurian, T. Hedderly, M. Smith, J.-
P. Lin, M.D. King, T.T. Warner, H. Pall, P. Chinnery, A. Whone,
K.K. Mantripragada, N.M. Williams, M.J. Owen, D.J. Blake,
H.R. Morris (Cardiff, United Kingdom)
946 Association of GWAS loci with PD in China
X.-L. Chang, X.-Y. Mao, H.-H. Li, J.-H. Zhang, N.-N. Li, J.-
M. Burgunder, R. Peng, E.-K. Tan (Chengdu, Sichuan, China)
947 Clinical and pathological findings in three cases of LRRK2 G2019S
mutation carries with PD
M. Poulopoulos, E. Cortes, J.P.G. Vonsattel, S. Fahn, C. Waters,
L. Cote, C. Moskowitz, L.S. Honig, L.N. Clark, K.S. Marder, R. Alcalay
(New York, New York, USA)
948 Is LINGO2 genetic variant associated with essential tremor and
Parkinson’s disease?
K.M. Prakash, N.A. Harun, L.C. Tan, W.-L. Au, E.-K. Tan (Singapore,
Singapore)
949 Gene-environment interaction in a mouse tauopathy-model
G. Respondek, E. Yamada, P. Champy, W. Oertel, G. Höglinger
(Marburg, Germany)
950 Mitochondrial gene mutations resulting in ataxia
L.S. Rosenthal, E.K. Reed, J.M. Savitt (Baltimore, Maryland, USA)
951 Gene methylation in early Parkinson’s disease
J.S. Schneider, D.W. Anderson, S. Ho, X. Zhang (Philadlephia,
Pennsylvania, USA)
15 th INTERNATIONAL CONGRESS OF PARKINSON’S
DISEASE AND MOVEMENT DISORDERS
952 Phenotypic expression and founder effect of PANK2 1583C>T
(T528M) mutation in Serbian patients
M.V. Svetel, K. Hoertnagel, M. Hartig, I. Novakovic, V. Dobricic,
M. Krajinovic, C. Beaubois, V.S. Kostic (Belgrade, Serbia)
953 Clinical and genetic aspects in patients with idiopathic Parkinson’s
disease
A.N. Taravari, I. Petrov, V. Petrova, M. Milanovska, M. Ismajli-Marku
(Skopje, Macedonia, The Former Yugoslav Republic of)
954 GCH1 variation altering expression levels in autosomal dominant
dopa-responsive dystonia and in idiopathic Parkinson’s disease
J. Theuns, D. Crosiers, K. Nuytemans, B. Meeus, K. Sleegers,
E. Corsmit, E. Elinck, K. Peeters, M. Mattheijssens, S. Engelborghs,
B. Pickut, P. Cras, P.P. De Deyn, C. Van Broeckhoven (Antwerpen,
Belgium)
955 Functional polymorphisms of dopamine pathway genes (COMT,
MAOB and DBH) in the development of Parkinson’s disease: A study
with multiple stratifications and risk factor adjustments
T. Xie, K. Marder, Y. Tang, A. Levey, R. Santella, M. Tang, Q. Wang,
J. Cubells, W. Duan, L. Clark, S. Fahn (Chicago, Illinois, USA)
956 Molecular-genetic analyses of early form of a Parkinson’s disease in
Belarus
O.A. Yacutc, K.A. Mosse, S.A. Likhachev, I.V. Pleshko (Minsk, Belarus)
957 The transcription factor Pitx3 is a risk factor for Parkinson’s disease
in a Chinese Han population
L. Yu, Z. Lin, Y. Liu, F. Hu, X. He, Z. Liu, Y. Xu (Chengdu, Sichuan,
China)
958 Relative contribution of SCA2, SCA3 and SCA17 in Korean patients
with parkinsonism and ataxia
J.Y. Yun, W.-W. Lee, H.J. Kim, J.S. Kim, J.-M. Kim, B.S. Jeon
(Seongnam, Korea)
959 A new hyperekplexia family with a recessive deletion in the GLRA1
gene
E. Zoons, I.B. Ginjaar, P.A.D. Bouma, H.A. Carpay, M.A.J. Tijssen
(Amsterdam, Netherlands)
960 Rapid-onset dystonia-parkinsonism: Searching for a new gene
K. Zschiedrich, A. Weissbach, S. Winkler, K. Isbruch, M. Schwarz,
C. Klein, K. Lohmann (Lübeck, Germany)
History
961 Women pioneers in basal ganglia surgery
G.-M. Hariz, S. Rehncrona, K. Hamberg, M. Hariz, P. Limousin (Umeå,
Sweden)
962 Albert Schweitzer: A patient with writer’s cramp
P. Tacik, C. Schrader, E. Weber, R. Dengler, D. Dressler (Hannover,
Lower Saxony, Germany)
Lewy Body Dementia and other dementias in movement
disorders
963 CSF levels of sAPP-a and sApp-b levels in dementia with Lewy body
and Parkinson’s disease dementia
E. Mulugeta, K. Blennow, H. Zetterberg, C. Ballard, L. Minthon,
E. Londos, O. Hansson, D. Aarsland (Stavanger, Norway)
TORONTO
119
June 5–9, 2011 Toronto, ON, C anada
Abstracts
by topic